Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-004714
Filing Date
2023-02-23
Accepted
2023-02-23 09:03:02
Documents
85
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vcel-20221231.htm   iXBRL 10-K 2278090
2 EX-21.1 ex211subsidiariesofregistr.htm EX-21.1 1556
3 EX-23.1 ex231consentofregisteredin.htm EX-23.1 2307
4 EX-31.1 ex311certificationq42022.htm EX-31.1 12132
5 EX-31.2 ex312certificationq42022.htm EX-31.2 12090
6 EX-32.1 ex321certificationq42022.htm EX-32.1 10067
12 vcel-20221231_g1.jpg GRAPHIC 210586
  Complete submission text file 0001628280-23-004714.txt   9898873

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20221231.xsd EX-101.SCH 49315
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcel-20221231_cal.xml EX-101.CAL 130603
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcel-20221231_def.xml EX-101.DEF 230620
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20221231_lab.xml EX-101.LAB 765610
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20221231_pre.xml EX-101.PRE 469079
79 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20221231_htm.xml XML 1553940
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35280 | Film No.: 23656374
SIC: 2836 Biological Products, (No Diagnostic Substances)